These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 8320247)

  • 41. Impacts of low-dose steroids and prophylactic monoclonal versus polyclonal antibodies on acute rejection in cyclosporine- and azathioprine-immunosuppressed cardiac allografts.
    Laufer G; Laczkovics A; Wollenek G; Schreiner W; Sochor H; Holzinger C; Buchelt M; Fasol R; Wolner E
    J Heart Transplant; 1989; 8(3):253-61. PubMed ID: 2661776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heart transplantation in females.
    Esmore D; Keogh A; Spratt P; Jones B; Chang V
    J Heart Lung Transplant; 1991; 10(3):335-41. PubMed ID: 1854761
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. OKT3 monoclonal antibody given for ten versus fourteen days as immunosuppressive prophylaxis in heart transplantation.
    Hegewald MG; O'Connell JB; Renlund DG; Lee HR; Burton NA; Karwande SV; Jones KW; Lassetter JE; Bristow MR
    J Heart Transplant; 1989; 8(4):303-9; discussion 309-10. PubMed ID: 2504897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A randomized prospective comparison of MALG with OKT3 for rescue therapy of acute myocardial rejection.
    Deeb GM; Bolling SF; Steimle CN; Dawe JE; McKay AL; Richardson AM
    Transplantation; 1991 Jan; 51(1):180-3. PubMed ID: 1824803
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rabbit antithymocyte globulin versus OKT3 induction therapy after heart-lung and lung transplantation: effect on survival, rejection, infection, and obliterative bronchiolitis.
    Barlow CW; Moon MR; Green GR; Gamberg P; Theodore J; Reitz BA; Robbins RC
    Transpl Int; 2001 Aug; 14(4):234-9. PubMed ID: 11512056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevention of rejection and graft loss with an aggressive quadruple immunosuppressive therapy regimen in children and adolescents.
    Conley SB; al-Uzri A; So S; Salvatierra O
    Transplantation; 1994 Feb; 57(4):540-4. PubMed ID: 8116038
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction.
    Tsamandas AC; Pham SM; Seaberg EC; Pappo O; Kormos RL; Kawai A; Griffith BP; Zeevi A; Duquesnoy R; Fung JJ; Starzl TE; Demetris AJ
    J Heart Lung Transplant; 1997 Jul; 16(7):723-34. PubMed ID: 9257254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quadruple immunosuppression: comparison of OKT3 and Minnesota antilymphocyte globulin.
    Light JA; Khawand N; Aquino A; Ali A; Korb S
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):10-3. PubMed ID: 2510505
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction immunotherapy in pediatric heart transplant recipients: a multicenter study.
    Boucek RJ; Naftel D; Boucek MM; Chinnock R; Morrow RW; Pahl E; DiSano S
    J Heart Lung Transplant; 1999 May; 18(5):460-9. PubMed ID: 10363691
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of outcomes between OKT3 and antithymocyte globulin for treatment of steroid-resistant rejection in hepatitis C liver transplant recipients.
    Benjamin MM; Dasher KJ; Trotter JF
    Transplantation; 2014 Feb; 97(4):470-3. PubMed ID: 24142032
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optimal perioperative immunosuppression in cardiac transplantation using rabbit antithymocyte globulin.
    Kormos RL; Armitage JM; Dummer JS; Miyamoto Y; Griffith BP; Hardesty RL
    Transplantation; 1990 Feb; 49(2):306-11. PubMed ID: 2137653
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adjuncts to triple-drug therapy after cardiac transplantation: a comparison of Nashville rabbit antithymocyte serum to OKT3.
    Aziz S; Kruse AP; Roby PV; Allen MD; Khan K; Fishbein D
    Transplant Proc; 1994 Oct; 26(5):2721-3. PubMed ID: 7940852
    [No Abstract]   [Full Text] [Related]  

  • 54. Prophylaxis with a short course of OKT3 in renal transplantation: comparative analysis with recipients treated either with prophylactic ATG or with CyA.
    Lloveras J; Puig JM; Oliveras A; Orfila A; Comerma I; Aubia J; Masramón J
    Transplant Proc; 1992 Feb; 24(1):43-4. PubMed ID: 1539335
    [No Abstract]   [Full Text] [Related]  

  • 55. Rejection prophylaxis with murine monoclonal CD-3 antibody (OKT3): considerations for early hospital discharge.
    Herrick CM; Mealey PC; Hagan ME; Holland CS; Volkman AK; Menlove RL
    J Heart Transplant; 1989; 8(1):67-70. PubMed ID: 2647934
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection.
    Wilde MI; Goa KL
    Drugs; 1996 May; 51(5):865-94. PubMed ID: 8861551
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The treatment of advanced cardiac allograft rejection.
    Sweeney MS; Macris MP; Frazier OH; Sinnott JT; Peric M; McAllister HA
    Ann Thorac Surg; 1988 Oct; 46(4):378-81. PubMed ID: 3140749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of induction therapy on rejection and survival in heart transplantation.
    Almenar L; García-Palomar C; Martínez-Dolz L; Chamorro C; Moro J; Zorio E; Arnau MA; Rueda J; Osa A; Cardo ML
    Transplant Proc; 2005 Nov; 37(9):4024-7. PubMed ID: 16386616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of OKT3 monoclonal antibody and anti-thymocyte globulin in the treatment of steroid-resistant acute allograft rejection in pediatric renal transplants.
    Mochon M; Kaiser B; Palmer JA; Polinsky M; Flynn JT; Caputo GC; Baluarte HJ
    Pediatr Nephrol; 1993 Jun; 7(3):259-62. PubMed ID: 8518094
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Altered specificity of alloreactive cardiac graft-infiltrating cells by prophylactic treatment with OKT3 or horse antilymphocyte globulin.
    Ouwehand AJ; Baan CC; Groeneveld K; Balk AH; Jutte NH; Bos E; Claas FH; Weimar W
    Transplantation; 1993 Jan; 55(1):154-8. PubMed ID: 8420041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.